Therapeutic Effects of Hemoperfusion in Treating Long-Acting Anticoagulant Rodenticide Poisoning
Blood Purification · 12.06.2026 · 1-8
DOI: 10.1159/000552075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, online erschienen am 12.06.2026. Verfasst von Jianguang Dong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Introduction
Second-generation anticoagulant rodenticides often cause severe bleeding that can be life threatening and have limited effective treatment options. This study aimed to evaluate the therapeutic efficacy of hemoperfusion in patients with rodenticide poisoning.
Methods
We retrospectively analyzed data of 148 patients diagnosed with rodenticide poisoning at the Fifth Medical Center of the Chinese PLA General Hospital (China) between 2014 and 2021. The patients were divided into hemoperfusion and non-hemoperfusion groups based on whether or not they had received blood purification treatment. We compared clinical characteristics, serum drug concentrations, durations of hospital stay, and durations of vitamin K1 (VK1) therapy between the two groups using univariate and multivariate analyses. Subgroup analyses were also conducted to assess the effect of hemoperfusion in patients poisoned with brodifacoum and bromadiolone.
Results
Of 148 screened patients, 115 patients were included (hemoperfusion [n = 24] and non-hemoperfusion [n = 91]). The rate of blood toxin clearance per unit time may have been faster in the hemoperfusion group. Subgroup analyses revealed that hemoperfusion significantly reduced the duration of VK1 therapy in patients poisoned with brodifacoum (p = 0.044).
Conclusion
Hemoperfusion effectively reduced serum rodenticide concentrations in patients with poisoning. Moreover, hemoperfusion can reduce the duration of VK1 therapy in patients poisoned by brodifacoum.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Disaster and Emergency Medicine, Tianjin University, Tianjin, China.
- Department of Ultrasound Medicine, The First Affiliated Hospital of USTC, Hefei, China.
- Department of Anaesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, China.
- Senior Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
- Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, China, wqiang07770@126.com.
- The First Clinical Medical College, Southern Medical University, Guangzhou, China, pzgsubject@126.com.
Zitieren
APA
Dong, J., Yin, B., Wu, J., Peng, X., Lu, X., Liu, Z., Fan, H., Zhao, Y., Liu, Z., Qiu, Z., Wen, Q., Pan, Z., & Lin, G. (2026). Therapeutic Effects of Hemoperfusion in Treating Long-Acting Anticoagulant Rodenticide Poisoning. Blood Purification, 1-8. https://doi.org/10.1159/000552075
Vancouver
Dong J, Yin B, Wu J, Peng X, Lu X, Liu Z, et al. Therapeutic Effects of Hemoperfusion in Treating Long-Acting Anticoagulant Rodenticide Poisoning. Blood Purification. 2026:1-8. doi:10.1159/000552075
BibTeX
@article{Dong2026,
author = {Dong, Jianguang and Yin, Bingling and Wu, Jieyi and Peng, Xiaobo and Lu, Xiaoxia and Liu, Zhongying and Fan, Haojun and Zhao, Yanmei and Liu, Ziquan and Qiu, Zewu and Wen, Qiang and Pan, Zhiguo and Lin, Guodong},
title = {Therapeutic Effects of Hemoperfusion in Treating Long-Acting Anticoagulant Rodenticide Poisoning},
journal = {Blood Purification},
year = {2026},
pages = {1--8},
doi = {10.1159/000552075}
}
EUVIMED